PET-IMAGING OF HYPOXIA USING 89ZR-LABELED CG250-F(AB′)2

被引:0
|
作者
Hoeben, B. [1 ]
Kaanders, J. [1 ]
Laverman, P. [2 ]
Oosterwijk, E. [3 ]
Oyen, W. [2 ]
Boerman, O. [2 ]
Bussink, J. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Radiat Oncol, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Nucl Med, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Urol, Nijmegen, Netherlands
关键词
D O I
10.1016/S0167-8140(10)80004-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10
引用
收藏
页码:S7 / S7
页数:1
相关论文
共 50 条
  • [41] 89Zr-labeled anti-PD-L1 CX-072 PET imaging in human xenograft and syngeneic tumors
    Giesen, D.
    Broer, L. N.
    Lub-De Hooge, M. N.
    Popova, I.
    Howng, B.
    Vasiljeva, O.
    de Vries, E. G. E.
    Pool, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [42] In vivo imaging of 89Zr-labeled poly(2-ethyl-2-oxazoline)s and poly(ethylene glycol)s
    Verbrugghen, T.
    Wyffels, L.
    Monnery, B.
    Hoogenboom, R.
    Staelens, S.
    NUCLEAR MEDICINE AND BIOLOGY, 2014, 41 (07) : 645 - 645
  • [43] Imaging and quantification of 89Zr-labeled antibodies in rhesus monkeys up to 30 days post-injection using the mini-EXPLORER PET scanner
    Berg, Eric
    Zhang, Xuezhu
    Gill, Herman
    Marik, Jan
    Tarantal, Alice
    Williams, Simon
    Cherry, Simon
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [44] PET imaging of tumor hypoxia using 18F-labeled pimonidazole
    Busk, Morten
    Jakobsen, Steen
    Horsman, Michael R.
    Mortensen, Lise S.
    Iversen, Ane B.
    Overgaard, Jens
    Nordsmark, Marianne
    Ji, Xiaosheng
    Lee, David Y.
    Raleigh, James R.
    ACTA ONCOLOGICA, 2013, 52 (07) : 1300 - 1307
  • [45] μPET imaging of the pharmacokinetic behavior of medium and high molar mass 89Zr-labeled poly(2-ethyl-2-oxazoline) in comparison to poly(ethylene glycol)
    Wyffels, Leonie
    Verbrugghen, Thomas
    Monnery, Bryn D.
    Glassner, Mathias
    Stroobants, Sigrid
    Hoogenboom, Richard
    Staelens, Steven
    JOURNAL OF CONTROLLED RELEASE, 2016, 235 : 63 - 71
  • [46] Positron emission tomography (PET) with 89Zr-labeled trastuzumab (89Zr-trastuzumab): Monitoring HER2 expression in HER2-positive gastric cancer in vivo
    Janjigian, Y. Y.
    Villegas, N. T.
    Holland, J. P.
    Shah, M. A.
    Divilov, V.
    Kelsen, D. P.
    Lewis, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [47] First-in-Human Total-Body PET/CT Imaging Using 89Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma
    Kulkarni, Harshad R.
    Maupin, Kevin A.
    Brennan, Tina
    Forsberg, Jens
    Rogers, Dan
    Olson, Mark
    Mancini, Brandon R.
    Chang, Anthony
    Chandana, Sreenivasa R.
    Kobayashi, Ryohei
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (11) : 1815 - 1815
  • [48] Preclinical evaluation of 89Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model
    Sugyo, Aya
    Tsuji, Atsushi B.
    Sudo, Hitomi
    Nagatsu, Kotaro
    Koizumi, Mitsuru
    Ukai, Yoshinori
    Kurosawa, Gene
    Zhang, Ming-Rong
    Kurosawa, Yoshikazu
    Saga, Tsuneo
    NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (03) : 286 - 294
  • [49] PET imaging of colon cancer CD73 expression using cysteine site-specific 89Zr-labeled anti-CD73 antibody
    Jung, Kyung-Ho
    Kim, Mina
    Jung, Hye Jin
    Koo, Hyun Jung
    Kim, Jung-Lim
    Lee, Hyunjong
    Lee, Kyung-Han
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] Rectal delivery of 89Zr-labeled infliximab-loaded nanoparticles enables PET imaging-guided localized therapy of inflammatory bowel disease
    Fan, Yeli
    Wang, Xinyu
    Yan, Ge
    Gao, Hongfang
    Yang, Min
    JOURNAL OF MATERIALS CHEMISTRY B, 2023, 11 (47) : 11228 - 11234